As of 2026-03-26, the Intrinsic Value of Thermo Fisher Scientific Inc (TMO) is 464.11 USD. This TMO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 490.77 USD, the upside of Thermo Fisher Scientific Inc is -5.40%.
The range of the Intrinsic Value is 322.27 - 789.87 USD
Based on its market price of 490.77 USD and our intrinsic valuation, Thermo Fisher Scientific Inc (TMO) is overvalued by 5.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 322.27 - 789.87 | 464.11 | -5.4% |
| DCF (Growth 10y) | 388.31 - 875.77 | 537.62 | 9.5% |
| DCF (EBITDA 5y) | 434.43 - 625.98 | 521.05 | 6.2% |
| DCF (EBITDA 10y) | 475.89 - 709.12 | 579.00 | 18.0% |
| Fair Value | 90.15 - 90.15 | 90.15 | -81.63% |
| P/E | 392.71 - 523.91 | 453.52 | -7.6% |
| EV/EBITDA | 454.88 - 623.79 | 527.10 | 7.4% |
| EPV | 129.06 - 187.69 | 158.37 | -67.7% |
| DDM - Stable | 139.83 - 371.09 | 255.46 | -47.9% |
| DDM - Multi | 252.01 - 524.83 | 341.08 | -30.5% |
| Market Cap (mil) | 182,311.23 |
| Beta | 1.01 |
| Outstanding shares (mil) | 371.48 |
| Enterprise Value (mil) | 211,844.23 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.70% |
| Cost of Debt | 4.54% |
| WACC | 9.50% |